7/12/2023: Due to reagent discontinuation, the N-Telopeptide, Serum assay will no longer be available. 

Beta-Cross-Linked, Serum (CTX) is an alternative marker of bone resorption and has been recommended by the International Osteoporosis Foundation and the Endocrine Society for monitoring response to therapy in postmenopausal osteoporosis.